Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy

Platinum-based therapeutics are used to manage many forms of cancer, but frequently result in peripheral neuropathy. Currently, the only option available to attenuate chemotherapy-induced neuropathy is to limit or discontinue this treatment. Sphingosine 1-phosphate (S1P) is a lipid-based signaling m...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Biol Chem
Main Authors: Wang, Wei, Xiang, Ping, Chew, Wee Siong, Torta, Federico, Bandla, Aishwarya, Lopez, Violeta, Seow, Wei Lun, Lam, Brenda Wan Shing, Chang, Jing Kai, Wong, Peiyan, Chayaburakul, Kanokporn, Ong, Wei-Yi, Wenk, Markus R., Sundar, Raghav, Herr, Deron R.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Biochemistry and Molecular Biology 2020
נושאים:
Editors' Picks
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983853/
https://ncbi.nlm.nih.gov/pubmed/31882542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA119.011699
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים